These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 37072781)

  • 1. Dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy.
    Hrabalova P; Bohuslavova R; Matejkova K; Papousek F; Sedmera D; Abaffy P; Kolar F; Pavlinkova G
    Cardiovasc Diabetol; 2023 Apr; 22(1):88. PubMed ID: 37072781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprogramming of the developing heart by Hif1a-deficient sympathetic system and maternal diabetes exposure.
    Kolesova H; Hrabalova P; Bohuslavova R; Abaffy P; Fabriciova V; Sedmera D; Pavlinkova G
    Front Endocrinol (Lausanne); 2024; 15():1344074. PubMed ID: 38505753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects of Hif1a mutation and maternal diabetes on the offspring heart.
    Cerychova R; Bohuslavova R; Papousek F; Sedmera D; Abaffy P; Benes V; Kolar F; Pavlinkova G
    Cardiovasc Diabetol; 2018 May; 17(1):68. PubMed ID: 29753320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial deficiency of HIF-1α stimulates pathological cardiac changes in streptozotocin-induced diabetic mice.
    Bohuslavova R; Kolar F; Sedmera D; Skvorova L; Papousek F; Neckar J; Pavlinkova G
    BMC Endocr Disord; 2014 Feb; 14():11. PubMed ID: 24502509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin-induced diabetic rats: implications for cardiac sympathetic dysinnervation complicating diabetes.
    Schmid H; Forman LA; Cao X; Sherman PS; Stevens MJ
    Diabetes; 1999 Mar; 48(3):603-8. PubMed ID: 10078563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIF-1α is required for development of the sympathetic nervous system.
    Bohuslavova R; Cerychova R; Papousek F; Olejnickova V; Bartos M; Görlach A; Kolar F; Sedmera D; Semenza GL; Pavlinkova G
    Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13414-13423. PubMed ID: 31196952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetes.
    Kellogg AP; Converso K; Wiggin T; Stevens M; Pop-Busui R
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H453-61. PubMed ID: 19060127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CCR2 in the Development of Streptozotocin-Treated Diabetic Cardiomyopathy.
    Tan X; Hu L; Shu Z; Chen L; Li X; Du M; Sun D; Mao X; Deng S; Huang K; Zhang F
    Diabetes; 2019 Nov; 68(11):2063-2073. PubMed ID: 31439648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats.
    Yu W; Wu J; Cai F; Xiang J; Zha W; Fan D; Guo S; Ming Z; Liu C
    PLoS One; 2012; 7(12):e52013. PubMed ID: 23251674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentially expressed microRNAs and their target genes in the hearts of streptozotocin-induced diabetic mice.
    Diao X; Shen E; Wang X; Hu B
    Mol Med Rep; 2011; 4(4):633-40. PubMed ID: 21584493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent Hypoxia Triggers Early Cardiac Remodeling and Contractile Dysfunction in the Time-Course of Ischemic Cardiomyopathy in Rats.
    Bourdier G; Détrait M; Bouyon S; Lemarié E; Brasseur S; Doutreleau S; Pépin JL; Godin-Ribuot D; Belaidi E; Arnaud C
    J Am Heart Assoc; 2020 Aug; 9(16):e016369. PubMed ID: 32805159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the polyol pathway on norepinephrine transporter reduction in diabetic cardiac sympathetic nerves: implications for heterogeneous accumulation of MIBG.
    Kiyono Y; Kajiyama S; Fujiwara H; Kanegawa N; Saji H
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):993-7. PubMed ID: 16261676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the polyol pathway on norepinephrine transporter reduction in diabetic cardiac sympathetic nerves: implications for heterogeneous accumulation of MIBG.
    Kiyono Y; Kajiyama S; Fujiwara H; Kanegawa N; Saji H
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):438-42. PubMed ID: 15821963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocytic toll-like receptor 2 knockout protects against diabetes-induced cardiac dysfunction.
    Lei L; Hu H; Lei Y; Feng J
    Biochem Biophys Res Commun; 2018 Nov; 506(3):668-673. PubMed ID: 30454704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes.
    Prakoso D; De Blasio MJ; Tate M; Kiriazis H; Donner DG; Qian H; Nash D; Deo M; Weeks KL; Parry LJ; Gregorevic P; McMullen JR; Ritchie RH
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H840-H852. PubMed ID: 32142359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased arrhythmia susceptibility in type 2 diabetic mice related to dysregulation of ventricular sympathetic innervation.
    Jungen C; Scherschel K; Flenner F; Jee H; Rajendran P; De Jong KA; Nikolaev V; Meyer C; Ardell JL; Tompkins JD
    Am J Physiol Heart Circ Physiol; 2019 Dec; 317(6):H1328-H1341. PubMed ID: 31625779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac sympathetic neuropathy and effects of aldose reductase inhibitor in streptozotocin-induced diabetic rats.
    Kurata C; Okayama K; Wakabayashi Y; Shouda S; Mikami T; Tawarahara K; Sugiyama T
    J Nucl Med; 1997 Nov; 38(11):1677-80. PubMed ID: 9374332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac-specific overexpression of CYP2J2 attenuates diabetic cardiomyopathy in male streptozotocin-induced diabetic mice.
    Ma B; Xiong X; Chen C; Li H; Xu X; Li X; Li R; Chen G; Dackor RT; Zeldin DC; Wang DW
    Endocrinology; 2013 Aug; 154(8):2843-56. PubMed ID: 23696562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockout of farnesoid X receptor aggravates process of diabetic cardiomyopathy.
    Qiang S; Tao L; Zhou J; Wang Q; Wang K; Lu M; Wang W; Han L; Xue S; Chen Y; Zhu H; Liu Z; Zhang Y
    Diabetes Res Clin Pract; 2020 Mar; 161():108033. PubMed ID: 32006644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis.
    Du JK; Yu Q; Liu YJ; Du SF; Huang LY; Xu DH; Ni X; Zhu XY
    Theranostics; 2021; 11(9):4207-4231. PubMed ID: 33754057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.